GO:0070098 chemokine-mediated signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070098 (chemokine-mediated signaling pathway) describes the molecular cascade triggered when a chemokine binds its receptor on a target cell, leading to regulation of downstream cellular processes such as transcription.
• Chemokine signaling controls directed cell migration, immune cell recruitment, and tissue remodeling, and is implicated in arthritis, cardiac hypertrophy, neuropathic pain, and skeletal disorders.
• Key receptors include CXCR2 and CXCR4, which activate Akt and antiapoptotic signaling through endocytosis-dependent mechanisms.
• WNK1 kinase regulates chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes, linking the pathway to cytoskeletal reorganization.
• Selectin-mediated signaling intersects with chemokine pathways to regulate integrin activity in neutrophils during inflammation.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect causal roles of chemokine pathway genes in disease.
Description
The chemokine-mediated signaling pathway (GO:0070098) is a fundamental biological process in which chemokines, a family of small cytokines, bind to their specific G protein-coupled receptors on the surface of target cells, initiating a cascade of intracellular signals that culminate in the regulation of downstream cellular responses, including transcription, cytoskeletal rearrangement, and directed migration. This pathway is central to immune surveillance, inflammation, and tissue homeostasis, and its dysregulation is associated with a wide range of human diseases, from osteoarthritis to cardiac hypertrophy and neuropathic pain. Researchers studying this pathway aim to understand how chemokine gradients are interpreted by cells and how receptor activation translates into specific physiological outcomes. Recent studies have highlighted the importance of chemokine signaling in skeletal disorders, where targeting these networks offers therapeutic potential. Moreover, chemokine-mediated signaling is not limited to immune cells; it also plays roles in nociceptive neurons and cardiac tissue, underscoring its broad physiological relevance. The pathway is tightly regulated at multiple levels, including receptor endocytosis, kinase activation, and interactions with other signaling modules such as selectin-mediated pathways. Understanding the molecular players and regulatory mechanisms of GO:0070098 is therefore critical for developing targeted interventions in inflammatory and degenerative diseases.
chemokine-mediated signaling pathway At A Glance
| GO ID | GO:0070098 |
|---|---|
| GO term | chemokine-mediated signaling pathway |
| Ontology | biological_process |
| Synonym | chemokine-mediated signalling pathway |
| Major function | Transduces chemokine signals from cell surface receptors to downstream cellular responses, including transcription, migration, and survival. |
| Key receptors | CXCR2, CXCR4, and other chemokine receptors |
| Key kinases | WNK1, Akt |
| Associated diseases | Osteoarthritis, cardiac hypertrophy, neuropathic pain, skeletal disorders |
What Is GO:0070098?
According to the Gene Ontology, GO:0070098 (chemokine-mediated signaling pathway) is defined as the series of molecular signals initiated by a chemokine binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. This process encompasses receptor activation, intracellular signal transduction, and the eventual modulation of gene expression or cell behavior, and is synonymous with chemokine-mediated signalling pathway.
Why Is chemokine-mediated signaling pathway Important in Cell Biology?
The chemokine-mediated signaling pathway is essential for coordinating immune cell trafficking, tissue repair, and host defense, but its aberrant activation contributes to chronic inflammatory diseases, cancer progression, and pain states. Understanding this pathway provides mechanistic insights into disease pathogenesis and reveals potential therapeutic targets, as demonstrated by studies targeting chemokine networks in skeletal disorders and cardiac remodeling.
• Controls directed migration of immune cells to sites of inflammation.
• Regulates transcription of inflammatory and survival genes.
• Implicated in osteoarthritis and inflammatory infiltrates.
• Mediates angiotensin II-induced cardiac hypertrophy through monocyte infiltration.
• Drives neuropathic pain via chemokine signaling in nociceptive neurons.
• Involved in benign prostatic hyperplasia and lower urinary tract symptoms.
• Modulates B lymphocyte polarity and F-actin dynamics through WNK1.
• Requires endocytosis for CXCR4-mediated Akt activation and antiapoptotic signaling.
• Cross-talks with selectin-mediated integrin regulation in neutrophils.
• Offers targets for therapeutic intervention in skeletal disorders.
What Happens During chemokine-mediated signaling pathway?
Chemokine binding and receptor activation
In simple terms: A chemokine molecule docks onto its receptor on the cell surface, switching the receptor on.
The pathway begins when a chemokine binds to its specific G protein-coupled receptor (GPCR) on the target cell membrane. This binding induces conformational changes in the receptor, leading to activation of heterotrimeric G proteins and initiation of intracellular signaling. For example, CXCL1 binding to CXCR2 activates downstream pathways that mediate monocyte infiltration in cardiac hypertrophy.
Intracellular signal transduction
In simple terms: The activated receptor triggers a relay of molecular signals inside the cell.
Upon activation, chemokine receptors stimulate multiple signaling cascades, including the Akt pathway. Endocytosis of the receptor is required for CXCR4-mediated Akt activation and antiapoptotic signaling, highlighting the importance of receptor internalization in signal propagation. Additionally, WNK1 kinase regulates chemokine-mediated F-actin dynamics and polarity in B lymphocytes, linking receptor activation to cytoskeletal reorganization.
Cytoskeletal rearrangement and cell migration
In simple terms: The cell changes its shape and moves toward the chemokine signal.
Chemokine signaling induces rapid changes in the actin cytoskeleton, enabling cell polarization and directed migration. In B lymphocytes, WNK1 signaling is essential for chemokine-mediated F-actin dynamics, polarity, and migration. Similarly, selectin-mediated signaling intersects with chemokine pathways to regulate integrin activity in neutrophils, facilitating adhesion and extravasation.
Regulation of downstream cellular processes
In simple terms: The signal reaches the nucleus and changes which genes are turned on or off.
The ultimate outcome of chemokine-mediated signaling is the regulation of downstream cellular processes, including transcription. For instance, chemokine signaling in osteoarthritis leads to inflammatory infiltrates and altered gene expression. In skeletal disorders, targeting chemokine networks modulates osteoclast and osteoblast activity, affecting bone remodeling.
Key Genes Involved in GO:0070098 chemokine-mediated signaling pathway
The following genes and proteins are central to the chemokine-mediated signaling pathway, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL1 | Chemokine ligand for CXCR2; mediates monocyte infiltration | Cardiac hypertrophy and remodeling |
| CXCR2 | Receptor for CXCL1; activates downstream signaling | Angiotensin II-induced cardiac hypertrophy |
| CXCR4 | Receptor for CXCL12; mediates Akt activation and antiapoptotic signaling | Requires endocytosis for signaling |
| WNK1 | Kinase regulating F-actin dynamics and polarity | B lymphocyte migration |
| Akt | Serine/threonine kinase; promotes cell survival | CXCR4-mediated antiapoptotic signaling |
| F-actin | Cytoskeletal component; enables cell migration | Chemokine-induced polarity |
| Integrin | Adhesion molecule; regulated by selectin signaling | Neutrophil extravasation |
| IGF1R | Receptor tyrosine kinase; involved in neuropathic pain | Follistatin-driven pain signaling |
| Follistatin | Protein that drives neuropathic pain via IGF1R | Neuropathic pain in mice |
| CCL2 | Chemokine ligand for CCR2; recruits monocytes | Inflammatory diseases |
| CCR2 | Receptor for CCL2; mediates monocyte chemotaxis | Inflammation and arthritis |
| CXCL12 | Chemokine ligand for CXCR4 | Stem cell homing and cancer |
| CXCL8 | Chemokine ligand for CXCR1/2; neutrophil recruitment | Inflammation |
| CXCR1 | Receptor for CXCL8 | Neutrophil activation |
| CCL5 | Chemokine ligand for CCR5 | Immune cell trafficking |
| CCR5 | Receptor for CCL5 | Inflammatory and infectious diseases |
| JAK2 | Kinase downstream of chemokine receptors | Signal transduction |
| STAT3 | Transcription factor activated by chemokine signaling | Gene regulation |
How Is chemokine-mediated signaling pathway Regulated?
The chemokine-mediated signaling pathway is regulated at multiple levels. Receptor endocytosis is required for CXCR4-mediated Akt activation, indicating that internalization is not merely a desensitization mechanism but a necessary step for certain signaling outcomes. Kinases such as WNK1 modulate cytoskeletal responses, thereby influencing cell polarity and migration. Additionally, selectin-mediated signaling can regulate integrin activity in neutrophils, demonstrating cross-talk between chemokine and adhesion pathways. In disease contexts, chemokine networks are subject to regulation by inflammatory mediators; for example, angiotensin II induces CXCL1-CXCR2 axis activation in cardiac hypertrophy. Targeting these regulatory nodes may provide therapeutic opportunities in skeletal disorders.
chemokine-mediated signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL1/CXCR2 | Cardiac hypertrophy and remodeling | Knockout mouse models |
| CXCR4 | Cancer and antiapoptotic signaling | Endocytosis-deficient knock-in cells |
| WNK1 | B lymphocyte migration disorders | WNK1 knockout B cells |
| Follistatin/IGF1R | Neuropathic pain | Conditional knockout mice |
| Chemokine networks | Skeletal disorders | Osteoclast-specific knockout |
Chemokine signaling in osteoarthritis
Osteoarthritis is characterized by inflammatory infiltrates and altered chemokine expression. Bioinformatics-led studies have identified chemokine-mediated signaling as a key pathway in osteoarthritis biomarkers and inflammatory infiltrates, suggesting that targeting this pathway could modulate disease progression.
Cardiac hypertrophy and remodeling
The CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodeling through regulation of monocyte infiltration. Inhibition of this axis reduces monocyte recruitment and attenuates cardiac remodeling, highlighting the pathological role of chemokine signaling in the heart.
Neuropathic pain
Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons, and chemokine-mediated signaling pathways are implicated in pain processing. This suggests that chemokine signaling in sensory neurons contributes to chronic pain states.
Skeletal disorders
Chemokine signaling networks are emerging as therapeutic targets in skeletal disorders, where they regulate osteoclast and osteoblast function. Targeting these networks may offer new treatments for bone diseases.
From chemokine-mediated signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CXCR2 mediate cardiac hypertrophy? | CXCR2 knockout mouse |
| Is endocytosis required for CXCR4 signaling? | CXCR4 endocytosis-deficient knock-in |
| How does WNK1 regulate B cell migration? | WNK1 knockout B lymphocytes |
| Does follistatin drive neuropathic pain via IGF1R? | Follistatin knockout mice |
| Can chemokine network targeting treat skeletal disorders? | Osteoclast-specific knockout |
| What is the role of selectin signaling in neutrophils? | Selectin knockout neutrophils |
How to Study the chemokine-mediated signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying transcriptional targets of chemokine signaling |
| Phosphoproteomics | Phosphorylation events | Mapping Akt activation downstream of CXCR4 |
| Live-cell imaging | F-actin dynamics and cell polarity | Visualizing B cell migration |
| CRISPR knockout screening | Gene essentiality for signaling | Discovering novel pathway components |
| Flow cytometry | Immune cell infiltration | Quantifying monocyte recruitment in cardiac tissue |
| Western blot | Protein activation status | Detecting Akt phosphorylation |
| ELISA | Chemokine secretion | Measuring CXCL1 levels in hypertrophy models |
| Mouse genetics | In vivo pathway function | Testing CXCR2 knockout in cardiac remodeling |
Transcriptomic profiling
RNA sequencing can identify global changes in gene expression following chemokine stimulation, revealing downstream transcriptional targets of GO:0070098. This approach has been used to discover biomarkers and inflammatory infiltrates in osteoarthritis.
Proteomic and phosphoproteomic analysis
Mass spectrometry-based proteomics can quantify phosphorylation events in chemokine signaling, such as Akt activation downstream of CXCR4. This method helps map the signaling cascade and identify novel regulators.
Live-cell imaging
Fluorescence microscopy of F-actin dynamics and cell polarity allows real-time visualization of chemokine-induced migration. This technique has been instrumental in defining the role of WNK1 in B lymphocyte polarity.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes required for chemokine-mediated signaling, such as receptors, kinases, and cytoskeletal regulators. This unbiased approach accelerates target discovery in diseases like skeletal disorders.
How CRISPR Can Be Used to Study GO:0070098 chemokine-mediated signaling pathway
Knockout
CRISPR knockout of chemokine receptors or downstream kinases can abolish signaling and reveal their necessity in processes such as monocyte infiltration and cardiac hypertrophy. For example, CXCR2 knockout mice show reduced angiotensin II-induced remodeling.
Point Mutation
Introducing point mutations in chemokine receptors can dissect specific signaling motifs. For instance, mutating endocytosis motifs in CXCR4 can test whether internalization is required for Akt activation.
Knock-in
Knock-in of tagged or fluorescently labeled chemokine receptors allows real-time tracking of receptor trafficking and signaling in live cells, providing insights into spatiotemporal dynamics.
Overexpression
Overexpression of chemokines or their receptors can amplify signaling and model pathological states such as chronic inflammation or cancer. This approach is useful for studying gain-of-function mechanisms in disease.
How EDITGENE Supports chemokine-mediated signaling pathway Research
Researchers studying chemokine-mediated signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway activation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of chemokine signaling components.
Contact EDITGENE today to design your custom CRISPR model for chemokine-mediated signaling pathway research.
Frequently Asked Questions About chemokine-mediated signaling pathway
What is GO:0070098?
GO:0070098 is the Gene Ontology term for chemokine-mediated signaling pathway, defined as the series of molecular signals initiated by a chemokine binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
What genes are involved in chemokine-mediated signaling pathway?
Key genes include chemokine ligands such as CXCL1, CXCL12, and CCL2, receptors such as CXCR2, CXCR4, and CCR2, and downstream kinases like WNK1 and Akt.
What diseases are associated with chemokine-mediated signaling pathway?
This pathway is implicated in osteoarthritis, cardiac hypertrophy, neuropathic pain, skeletal disorders, and benign prostatic hyperplasia.
How is chemokine-mediated signaling regulated?
It is regulated by receptor endocytosis, kinase activation (e.g., WNK1), and cross-talk with selectin-mediated integrin signaling.
What is the role of CXCR4 in chemokine signaling?
CXCR4 mediates Akt activation and antiapoptotic signaling, and its endocytosis is required for these downstream effects.
How does WNK1 regulate chemokine signaling?
WNK1 regulates chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes.
What experimental models are used to study chemokine-mediated signaling?
Common models include knockout mice, endocytosis-deficient knock-in cells, and CRISPR knockout cell lines.
What is the CXCL1-CXCR2 axis?
The CXCL1-CXCR2 axis is a chemokine signaling pathway that mediates angiotensin II-induced cardiac hypertrophy and remodeling through monocyte infiltration.
How can CRISPR be used to study chemokine signaling?
CRISPR knockout, point mutation, knock-in, and overexpression can dissect gene function in chemokine pathways, while CRISPR screens identify novel regulators.
What methods are used to study chemokine-mediated signaling?
Methods include RNA-seq, phosphoproteomics, live-cell imaging, flow cytometry, and CRISPR screening.
Conclusion
The chemokine-mediated signaling pathway (GO:0070098) is a critical biological process that governs immune cell migration, tissue remodeling, and disease pathogenesis. Its components, from chemokine ligands and receptors to downstream kinases and cytoskeletal regulators, are validated targets in conditions such as osteoarthritis, cardiac hypertrophy, and neuropathic pain. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate the mechanistic details and therapeutic potential of this pathway.
References
- 1. Hu X et al.. 2022. Bioinformatics-Led Discovery of Osteoarthritis Biomarkers and Inflammatory Infiltrates.. Front Immunol 13:871008 PMID: 35734177
- 2. Hwang IY et al.. 2024. Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling.. Sci Signal 17(851):eade1119 PMID: 39190707
- 3. Wang L et al.. 2018. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration.. Eur Heart J 39(20):1818-1831 PMID: 29514257
- 4. Gao W et al.. 2025. Targeting chemokine signaling networks for therapeutics in skeletal disorders.. Front Endocrinol (Lausanne) 16:1667440 PMID: 41416066
- 5. Jiang BC et al.. 2024. Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons.. Sci Transl Med 16(769):eadi1564 PMID: 39413164
- 6. Macoska JA. 2011. Chemokines and BPH/LUTS.. Differentiation 82(4-5):253-60 PMID: 21600689
- 7. English EJ et al.. 2018. Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling.. J Biol Chem 293(29):11470-11480 PMID: 29899118
- 8. Cappenberg A et al.. 2022. Selectin-Mediated Signaling-Shedding Light on the Regulation of Integrin Activity in Neutrophils.. Cells 11(8) PMID: 35455989
